Cargando…

Epigenetic Profiling of PTPN11 Mutant JMML Hematopoietic Stem and Progenitor Cells Reveals an Aberrant Histone Landscape

SIMPLE SUMMARY: Juvenile myelomonocytic leukemia (JMML) is a deadly pediatric leukemia with limited treatment options and poor clinical outcomes. Effective targeted treatment strategies are an urgent unmet need. To improve outcomes for this pediatric patient population, we examined the structure of...

Descripción completa

Detalles Bibliográficos
Autores principales:	Sinha, Roshani, Dvorak, Mai, Ganesan, Ananthakrishnan, Kalesinskas, Larry, Niemeyer, Charlotte M., Flotho, Christian, Sakamoto, Kathleen M., Lacayo, Norman, Patil, Rachana Vinay, Perriman, Rhonda, Cepika, Alma-Martina, Liu, Yunying Lucy, Kuo, Alex, Utz, Paul J., Khatri, Purvesh, Bertaina, Alice
Formato:	Online Artículo Texto
Lenguaje:	English
Publicado:	MDPI 2023
Materias:	Article
Acceso en línea:	https://www.ncbi.nlm.nih.gov/pmc/articles/PMC10650722/ https://www.ncbi.nlm.nih.gov/pubmed/37958378 http://dx.doi.org/10.3390/cancers15215204

Ejemplares similares

Inferring direction of associations between histone modifications using a neural processes-based framework
por: Ganesan, Ananthakrishnan, et al.
Publicado: (2022)

P1000: JUVENILE MYELOMONOCYTIC LEUKEMIA (JMML) INHIBITS T CELL PROLIFERATION VIA THE ECTONUCLEOTIDASE CD39 AND THE PURINERGIC NETWORK
por: Rajak, Jovana, et al.
Publicado: (2023)

Mass-Cytometry-Based Quantification of Global Histone Post-Translational Modifications at Single-Cell Resolution Across Peripheral Immune Cells in IBD
por: Bai, Lawrence, et al.
Publicado: (2022)

MicroRNA fingerprints in juvenile myelomonocytic leukemia (JMML) identified miR-150-5p as a tumor suppressor and potential target for treatment
por: Leoncini, Pier Paolo, et al.
Publicado: (2016)

Stem cell origins of JMML
por: Sundaravel, Sriram, et al.
Publicado: (2021)

Increasing reproducibility, robustness, and generalizability of biomarker selection from meta-analysis using Bayesian methodology
por: Kalesinskas, Laurynas, et al.
Publicado: (2022)

Second allogeneic stem cell transplantation can rescue a significant proportion of patients with JMML relapsing after first allograft
por: Vinci, Luca, et al.
Publicado: (2023)

PTPN4 germline variants result in aberrant neurodevelopment and growth
por: Chmielewska, Joanna J., et al.
Publicado: (2021)

A 27-Year-Old Patient Fulfilling the Diagnostic Criteria of Both CMML and JMML
por: Elghazaly, Assem A., et al.
Publicado: (2016)

Wiskott-Aldrich Syndrome Presenting with JMML-Like Blood Picture and Normal Sized Platelets
por: Patil, Rajesh B., et al.
Publicado: (2016)

Despite mutation acquisition in hematopoietic stem cells, JMML-propagating cells are not always restricted to this compartment
por: Caye, Aurélie, et al.
Publicado: (2019)

KMT2A-MLLT3 AML Masquerading as JMML may Disguise Fatal Leukemia
por: Saad, Ashraf Abdullah, et al.
Publicado: (2019)

KLRD1-expressing natural killer cells predict influenza susceptibility
por: Bongen, Erika, et al.
Publicado: (2018)

Correction: Despite mutation acquisition in hematopoietic stem cells, JMML-propagating cells are not always restricted to this compartment
por: Caye, Aurélie, et al.
Publicado: (2020)

Inhibition of BTK and PI3Kδ impairs the development of human JMML stem and progenitor cells
por: Ramdas, Baskar, et al.
Publicado: (2022)

Engineered type 1 regulatory T cells designed for clinical use kill primary pediatric acute myeloid leukemia cells
por: Cieniewicz, Brandon, et al.
Publicado: (2020)

The catalytically inactive tyrosine phosphatase HD-PTP/PTPN23 is a novel regulator of SMN complex localization
por: Husedzinovic, Alma, et al.
Publicado: (2015)

Ancestry-based differences in the immune phenotype are associated with lupus activity
por: Slight-Webb, Samantha, et al.
Publicado: (2023)

Computational drug repositioning of atorvastatin for ulcerative colitis
por: Bai, Lawrence, et al.
Publicado: (2021)

Long-term proliferation of immature hypoxia-dependent JMML cells supported by a 3D in vitro system
por: Cani, Alice, et al.
Publicado: (2022)

PB2046: SHORT-TERM EFFICACY OF DECITABINE IN COMBINATION WITH LOW-DOSE CHEMOTHERAPY IN THE TREATMENT OF JMML: A RETROSPECTIVE STUDY
por: Cai, Y., et al.
Publicado: (2022)

JMML tumor cells disrupt normal hematopoietic stem cells by imposing inflammatory stress through overproduction of IL-1β
por: Yan, Yuhan, et al.
Publicado: (2022)

VAV1-Cre mediated hematopoietic deletion of CBL and CBL-B leads to JMML-like aggressive early-neonatal myeloproliferative disease
por: An, Wei, et al.
Publicado: (2016)

Concomitant deletion of Ptpn6 and Ptpn11 in T cells fails to improve anticancer responses
por: Ventura, Pedro M O, et al.
Publicado: (2022)

Current Treatment of Juvenile Myelomonocytic Leukemia
por: Mayerhofer, Christina, et al.
Publicado: (2021)

Alternative splicing variability: exactly how similar are two identical cells?
por: Perriman, Rhonda J, et al.
Publicado: (2011)

Sex Differences in the Blood Transcriptome Identify Robust Changes in Immune Cell Proportions with Aging and Influenza Infection
por: Bongen, Erika, et al.
Publicado: (2019)

Redoxing PTPN22 activity
por: Shumanska, Magdalena, et al.
Publicado: (2022)

Leukemogenic SHP2 mutations lead to erythropoietin independency of HCD-57 cells: a novel model for preclinical research of SHP2-mutant JMML
por: Zhao, Yuming, et al.
Publicado: (2023)

Curcumin inhibits proliferation of hepatocellular carcinoma cells by blocking PTPN1 and PTPN11 expression
por: Zhang, Jingru, et al.
Publicado: (2023)

PTPN22.6, a Dominant Negative Isoform of PTPN22 and Potential Biomarker of Rheumatoid Arthritis
por: Chang, Hui-Hsin, et al.
Publicado: (2012)

Genetic Variations of PTPN2 and PTPN22: Role in the Pathogenesis of Type 1 Diabetes and Crohn's Disease
por: Sharp, Robert C., et al.
Publicado: (2015)

The PTPN2/PTPN1 inhibitor ABBV-CLS-484 unleashes potent anti-tumour immunity
por: Baumgartner, Christina K., et al.
Publicado: (2023)

Cytokine signatures differentiate systemic sclerosis patients at high versus low risk for pulmonary arterial hypertension
por: Kolstad, Kathleen D., et al.
Publicado: (2022)

Early life immunity in the era of systems biology: understanding development and disease
por: Schaffert, Steven, et al.
Publicado: (2018)

Data Heterogeneity: The Enzyme to Catalyze Translational Bioinformatics?
por: Cahan, Eli M, et al.
Publicado: (2020)

Modeling the effect of PTPN22 in rheumatoid arthritis
por: Bourgey, Mathieu, et al.
Publicado: (2007)

Comprehensive analysis of PTPN gene family revealing PTPN7 as a novel biomarker for immuno-hot tumors in breast cancer
por: Wang, Fengxu, et al.
Publicado: (2022)

Host-response-based gene signatures for tuberculosis diagnosis: A systematic comparison of 16 signatures
por: Warsinske, Hayley, et al.
Publicado: (2019)

The FERM and PDZ Domain-Containing Protein Tyrosine Phosphatases, PTPN4 and PTPN3, Are Both Dispensable for T Cell Receptor Signal Transduction
por: Bauler, Timothy J., et al.
Publicado: (2008)

Cannot write session to /tmp/vufind_sessions/sess_8pe2ug6pif9fbv04l1bs5oh7gv